WORLD Senegal in talks to procure Chinese-made Sinopharm vaccine


Senegal in talks to procure Chinese-made Sinopharm vaccine


21:08, January 13, 2021

Senegal is in talks to acquire 200,000 doses of the Chinese-made Sinopharm vaccine, the government has said, intended as part of an imminent vaccination campaign against Covid-19.

A COVID-19 vaccine by China National Biotec Group Co. is displayed during the China International Fair for Trade in Services in Beijing on September 6. (Photo: VCG)

The West African state is already participating in Covax, a global collaboration scheme with pharmaceutical firms to ensure equitable distribution of COVID-19 vaccines.

However Health Minister Abdoulaye Diouf Sarr said in a video posted on social media late Tuesday that, separately, Senegal is also in talks with China to procure its Covid-19 vaccine Sinopharm.

The figure of 200,000 doses is a "working basis," Sarr explained, adding that the ministry intends to begin a roll-out "very soon".

As with other countries in Africa, Senegal's infection rate is far below levels reached in the West, having recorded over 21,000 coronavirus cases since March, with 480 deaths.

The nation of 16 million people is nonetheless battling a second wave of Covid-19, which forced the government to impose new restrictions last week.

"As well as Covax, we have to adopt a ... national strategy," Sarr said, explaining that health workers, the elderly and people with comorbidities will be prioritised for vaccination.

Some 20 percent of Senegal's population are initially expected to be innoculated, he added, but said the government aimed to become "more ambitious with time".

On Sunday, the Indian Ocean archipelago of the Seychelles began vaccinating its population with Sinopharm -- becoming the first African nation to launch a Covid-19 vaccination campaign.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue